ECV - Epihunter Clinical Validation

See also
Status	Clinical Trial	Phase
Completed	`NCT00545012` - A Safety and Efficacy Follow-up Study With Levetiracetam in Children (4-17 Years Old) Suffering From Absence Seizures	Phase 2
Completed	`NCT04439656` - Detecting Absence Seizures Using Eye Tracking
Recruiting	`NCT06093490` - Detecting Absence Seizures Using Hyperventilation and Eye Movement Recordings
Not yet recruiting	`NCT06310772` - Assessing Comorbidities in Epilepsy Using Eye Movement Recordings

See also

Status

Clinical Trial

Phase

Completed

NCT00545012 - A Safety and Efficacy Follow-up Study With Levetiracetam in Children (4-17 Years Old) Suffering From Absence Seizures

Phase 2

Completed

NCT04439656 - Detecting Absence Seizures Using Eye Tracking

Recruiting

NCT06093490 - Detecting Absence Seizures Using Hyperventilation and Eye Movement Recordings

Not yet recruiting

NCT06310772 - Assessing Comorbidities in Epilepsy Using Eye Movement Recordings

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT04615442
Study type	Interventional
Source	Epihunter NV
Contact
Status	Completed
Phase	N/A
Start date	May 1, 2020
Completion date	December 31, 2021

ECV - Epihunter Clinical Validation — ECV

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms